Dr. Lakshmi Nayak specializes in cancer of the brain at the Dana-Farber Cancer Institute in Mission Hill. Her average patient lives for only a year and a half, which means that Nayak has to have ...

SYDNEY, Nov. 1, 2023 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, is pleased to provide a preliminary update from the ongoing ...

“Patients with central nervous system involvement of large B-cell lymphoma were excluded from the studies that led to the FDA approval of axi-cel in relapsed/refractory large B-cell lymphoma,” said ...

(RTTNews) - Kazia Therapeutics Limited (KZIA,KZA.AX) provided a preliminary update from the ongoing investigator-initiated Phase 2 clinical trial evaluating paxalisib as monotherapy treatment in ...